Companies

DBV Technologies S.A. (DBVT) SEC filings

CIK 0001613780 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq, OTC · incorporated in I0 · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)5.6 M15.7 M4.8 M
Net income (USD)-97.8 M
Diluted EPS (USD/shares)-1.05-0.76-1.24

Latest filings

FiledFormDescriptionPeriod
2026-09-308-K8-K items 8.01,9.012026-09-29
2026-08-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-08-06SCHEDULE 13GSCHEDULE 13G
2026-07-31442026-07-29
2026-07-27S-3ASRS-3ASR
2026-07-168-K8-K items 2.02,9.012026-07-16
2026-07-1610-Q10-Q2026-06-30
2026-06-298-K8-K items 8.01,9.012026-06-29
2026-06-058-K8-K items 5.02,9.012026-06-03
2026-06-04S-8S-8
2026-06-038-K8-K items 5.03,5.07,9.012026-06-03
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-13SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-12SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-11ARSARS2025-12-31
2026-05-11DEF 14ADEF 14A2026-06-03
2026-05-058-K8-K items 5.02,9.012026-04-30
2026-05-05SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-04S-8S-8
2026-05-01PRE 14APRE 14A2026-06-03
2026-04-308-K8-K items 2.02,9.012026-04-30
2026-04-3010-Q10-Q2026-03-31
2026-04-3010-K/A10-K/A2025-12-31
2026-04-16332025-10-30

Forms on file (last 1,000): 6-K 197, 8-K 74, 4 39, SC 13G/A 34, 3 22, 10-Q 17, SC 13G 16, SCHEDULE 13G/A 15. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=DBVT (0.002 USD), /gw/filings/filings?ticker=DBVT&form=8-K, /gw/filings/facts?ticker=DBVT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange